Refine your search
Collections
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Venkateswara Rao, T.
- Review: Transdermal Patch
Abstract Views :583 |
PDF Views:0
Authors
Affiliations
1 Bapatla College of Pharmacy, Bapatla, Guntur (D.T), Andhra Pradesh, IN
1 Bapatla College of Pharmacy, Bapatla, Guntur (D.T), Andhra Pradesh, IN
Source
Research Journal of Pharmaceutical Dosage Form and Technology, Vol 5, No 1 (2013), Pagination: 12-16Abstract
Transdermal drug delivery systems (TDDS) or “patches,” are dosage forms designed to deliver effective amount of drug across a patient’s skin. In order to deliver therapeutic agents through the human skin for systemic effects, the comprehensive morphological, biophysical and physicochemical properties of the skin are to be considered. Transdermal delivery is advantageous over injectables and oral routes by increasing patient compliance and avoiding first pass metabolism respectively. Several important advantages of transdermal drug delivery are limitation of hepatic first pass metabolism, enhancement of therapeutic efficiency and maintenance of steady plasma level of the drug. The evidence of percutaneous drug absorption found through measurable blood levels of the drug, detectable excretion of the drug and its metabolites in the urine and through the clinical response of the patient to the administered drug therapy.Keywords
TDDS, Evaluations.References
- Rhaghuram reddy k, Muttalik S and Reddy S. Once – daily sustained- release matrix tablets of nicorandil: formulation and invitro evaluation. AAPS Pharm.Sci.Tech. 2003;4:4.
- Shaila L, Pandey S and Udupa N. Design and evaluation of matrix type membrane controlled Transdermal drug delivery system of nicotin suitable for use in smoking cessation. Indian Journ. Pharm. Sci. 2006;68: 179-184
- Aarti N, Louk A.R.M.P, Russsel.O.P and Richard H.G. Mechanism of oleic acid induced skin permeation enhancement in vivo in humans. Jour. control. Release 1995; 37: 299-306.
- Wade A and Weller P.J. Handbook of pharmaceutical Excipients. Washington, DC: American Pharmaceutical Publishing Association 1994; 362-366.
- Lec S.T, Yac S.H, Kim S.W and Berner B. One way membrane for Transdermal drug delivery systems / system optimization. Int. J Pharm. 1991; 77: 231 - 237.
- Vyas S.P and Khar R.K. Targetted and controlled Drug Delivery Novel carrier system1st Ed., CBS Publishers and distributors, New Delhi, 2002; 411- 447.
- Singh J, Tripathi K.T and SakiaT.R. Effect of penetration enhancers on the invitro transport of ephedrine through rate skin and human epidermis from matrix based Transdermal formulations. Drug Dev.Ind. Pharm. 1993; 19: 1623-1628.
- Wade A, Weller P.J. Handbook of pharmaceutical Excipients Washington, DC: American Pharmaceutical Publishing Association; 1994: 362- 366
- Design and Development of Bilayer Floating Tablets of Diltiazem Hydrochloride
Abstract Views :187 |
PDF Views:0
Authors
Affiliations
1 Bapatla College of Pharmacy, Bapatla Educational Society, Bapatla, Guntur District, Andhra Pradesh-522101, IN
2 Bapatla College of Pharmacy, Bapatla Educational Society, Bapatla, Guntur District, Andhra Pradesh-522101, IN
1 Bapatla College of Pharmacy, Bapatla Educational Society, Bapatla, Guntur District, Andhra Pradesh-522101, IN
2 Bapatla College of Pharmacy, Bapatla Educational Society, Bapatla, Guntur District, Andhra Pradesh-522101, IN
Source
Research Journal of Pharmaceutical Dosage Form and Technology, Vol 3, No 6 (2011), Pagination: 304-309Abstract
Diltiazem hydrochloride is a calcium channel blocker which undergoes extensive hepatic first pass metabolism by liver; its absorption from upper part of GIT is very low and has poor oral bioavailability of 40% - 60%. In the present investigation Diltiazem Hydrochloride was formulated as a bilayer floating tablets in order to achieve the Gastric residence time and to minimize the flactuations in blood level i.e the drug was released from the SR layer. Bilayer floating tablets were prepared by wet granulation method. Immediate release layer was formulated by using various suerdisintegrantents such as sodium starch glycolate, croscarmellose sodium and crospovidone and sustained release layer was formulated by different grades hydrophilic polymers i.e. HPMCK4M, HPMCE5 and HPMCK100M.The drug- excipient compatibility studies were conducted by IR spectroscopy. The tablets were evaluated for weight variation hardness, friability, drug content, swelling index, in-vitro buoyancy studies and in-vitro dissolution studies. The drug was released from an immediate release layer was 20mins followed by sustained release layer for 12hrs.The dissolution data were fitted into zero order, first order, Higuchi and Peppas mechanism. The drug release from the formulation F20 followed first order kinetics and exhibited Peppas transport mechanism.Keywords
Diltiazem Hydrochloride, SSG, Croscarmellose Sodium, Crosovidone, HPMCK4M, HMCE5, HPMCK100M.- Design and Development of Sustained Release Bilayered Tablets of Glipizide
Abstract Views :221 |
PDF Views:0
Authors
Affiliations
1 Bapatla College of Pharmacy, Bapatla Educational Society, Bapatla, Guntur district, Andhra Pradesh-522101, IN
1 Bapatla College of Pharmacy, Bapatla Educational Society, Bapatla, Guntur district, Andhra Pradesh-522101, IN
Source
Research Journal of Pharmaceutical Dosage Form and Technology, Vol 4, No 1 (2012), Pagination: 24-31Abstract
Glipizide, a second generation sulfonylurea is effective in controlling the blood glucose in patients with Non-Insulin Dependent Diabetes Mellitus. As Glipizide possess short biological half life (2-4 hrs), the concept of Bilayered tablet technology was used to formulate Glipizide as Sustained release tablet formulation. In order to overcome the disproportionate release of drug during intial period in case of general sustained release tablet formulations the concept of Bilayered tablets was utilized. Moreover by fabricating drugs in the form of Bilayered tablets, one can improve the Cmax and the speed of appearance of the drug in patient. Bilayered tablets formulated through Direct Compression was comprised of immediate, sustained release layers were formulated and evaluated through %Weight variation, Hardness, Friability, %Drug content, Swelling index and In-vitro drug release studies. 30% of the drug present in the immediate release layer was released within first 20 minutes and the remaining 70% of the drug release was sustained based on the polymer selected. The formulation comprised of HPC and HPMC as the polymers sustained the drug release for 12hrs and was found to be the best formulations.Keywords
Bilayered Tablets, Glipizide, PVP K-30, Spray Dried Lactose, HPC, HPMC.- Design and Development of Mucoadhesive Microcapsule of Aceclofenac for Oral Controlled Release by Ionic-Gelation Technique
Abstract Views :195 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmaceutics, Bapatla College of Pharmacy, Bapatla, Guntur (D.t), Andhra Pradesh-522101, IN
2 Department of Pharmaceutics, Bapatla College of Pharmacy, Bapatla, Guntur (D.t), Andhra Pradesh-522101, IN
1 Department of Pharmaceutics, Bapatla College of Pharmacy, Bapatla, Guntur (D.t), Andhra Pradesh-522101, IN
2 Department of Pharmaceutics, Bapatla College of Pharmacy, Bapatla, Guntur (D.t), Andhra Pradesh-522101, IN